UBE2C and neoplasm: In agreement with the previous studies, our data found significant DNA hypomethylation of UBE2C in CHOL, KIRC, and PCPG tumor tissues and a negative correlation between the methylation levels of UBE2C and its expression levels in multiple cancer types.